Cargando…
Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects
Background: Immunogenicity refers to the inherent ability of a molecule to stimulate an immune response. Aggregates are one of the major risk factors for the undesired immunogenicity of therapeutic antibodies (Ab) and may ultimately result in immune-mediated adverse effects. For Ab delivered by inha...
Autores principales: | Sécher, Thomas, Bodier-Montagutelli, Elsa, Parent, Christelle, Bouvart, Laura, Cortes, Mélanie, Ferreira, Marion, MacLoughlin, Ronan, Ilango, Guy, Schmid, Otmar, Respaud, Renaud, Heuzé-Vourc’h, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949695/ https://www.ncbi.nlm.nih.gov/pubmed/35336045 http://dx.doi.org/10.3390/pharmaceutics14030671 |
Ejemplares similares
-
Inhaled antibodies: formulations require specific development to overcome instability due to nebulization
por: Mayor, Alexie, et al.
Publicado: (2021) -
Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
por: Sécher, Thomas, et al.
Publicado: (2019) -
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
por: Pitiot, Aubin, et al.
Publicado: (2022) -
Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States
por: Ferreira, Marion, et al.
Publicado: (2021) -
Aerosol release, distribution, and prevention during aerosol therapy: a simulated model for infection control
por: Mac Giolla Eain, Marc, et al.
Publicado: (2021)